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Drugs and environmental chemicals can adversely affect the reproductive system. Currently,
available data indicate that the consequences of exposure depend on the nature of the chemical, its
target, and the timing of exposure relative to critical windows in development of the reproductive
system. The reproductive system is designed to produce gametes in far greater excess than would
seem to be necessary for the survival of species. Ten to hundreds of millions of spermatozoa are
generated daily by most adult male mammals, yet very few of these germ cells succeed in
transmitting their genetic material to the next generation. Although the number of oocytes
produced in mammalian females is more limited, and their production occurs only during fetal life,
most ovaries contain several orders of magnitude more oocytes than ever will be fertilized. Toxicant
exposures may affect critical events in the development of the reproductive system, ranging from
early primordial germ cell determination to gonadal differentiation, gametogenesis, external
genitalia, or signaling events regulating sexual behavior. Although there are differences between the
human reproductive system and that of the usual animal models, such models have been
extremely useful in assessing risks for key human reproductive and developmental processes. The
objectives for future studies should include the elucidation of the specific cellular and molecular
targets of known toxicants; the design of a systematic approach to the identification of reproductive
toxicants; and the development of sensitive, specific, and predictive animal models, minimally
invasive surrogate markers, or in vitro tests to assess reproductive system function during
embryonic, postnatal, and adult life. Key words: development, germ cell, oogenesis, reproductive
system, spermatogenesis, toxicant. - Environ Health Perspect 108(suppl 3):491-503 (2000).
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Although many of the important organiza-
tional events required to form a reproduc-
tively competent adult occur in utero, others
must occur throughout life. Ifexposures to
exogenous agents, either naturally occurring
or man made, have sufficient influence on
essential events, adult reproductive compe-
tency is diminished or abrogated. The time
periods during which the development ofthe
reproductive system is most sensitive to per-
turbation are reasonably well characterized in
the scientific literature. In this paper we
define critical windows ofdevelopment for
the reproductive system as follows: Critical
windows ofdevelopment are limited tempo-
ral intervals characterized by the occurrence
ofsets ofdynamic organizational events that
constitute periods during which exposures
may have the greatest potential to affect later
reproductive competency.
Concern for reproductive hazards dates
back at least to the Roman era, yet the etiol-
ogy or mechanism underlying these undesir-
able effects remains elusive in most instances.
Although it is clear that dysfunction of the
reproductive system can indeed be induced
by chemical agents, and that these agents
have effects on many processes, more
research is needed to elucidate the critical
windows during which an exposure may
adversely affect the reproductive system and
children's health.
Reproduction is cyclical in nature, so the
consideration of key periods of toxicant
exposure is arbitrary and thus could start at
various points in this cycle. Preconceptional
exposures will be defined here as exposures
that affect spermatogenesis in the adult male;
in the female these exposures will be consid-
ered as those from the point at which oocytes
progress from their arrested state in primor-
dial follicles and proceed to primary and sec-
ondary follicular phases, ovulate, and become
fertilized. During the first part ofthe prenatal
period (from fertilization to genital ridge
development), we are unaware ofexamples of
specific exposures associated with selective
deleterious effects on the reproductive system.
In both sexes, critical windows ofexposure
for the establishment ofthe stem-germ-cell
population in the gonads, as well as differen-
tiation ofthe urogenital system, occur during
the second part of prenatal development
(from genital ridge development to birth).
However, in the male, the major cell divisions
(mitotic and meiotic) that result in the pro-
duction of millions ofspermatozoa daily are
triggered only at puberty and continue
throughout life. In the female, oogonial dif-
ferentiation and all mitotic divisions, as well
as the initiation ofthe first meiotic division,
occur during fetal life. Consequently, in
females the critical window for exposures to
chemicals that affect gametogenesis is prenatal.
The pool ofoocytes that is established and
fixed during fetal life declines significantly
after birth and more gradually after puberty
until reproductive senescence in rodents, or
until it is depleted and heralds menopause in
humans. Postnatal exposures may accelerate
this decline, impacting on fertility potential in
adulthood. In addition, exposures that alter
the regulation ofovarian function mayalter its
endocrine function, resulting in altered devel-
opment ofsecondary sex characteristics during
puberty and ovulatory competence at any
time duringadulthood.
Animal models, such as rodents and
nonhuman primates, are frequently used for
hazard identification and characterization of
the potential risk to human reproduction. To
use such models in studies designed to evalu-
ate potential risk to children's health (with
respect to their reproductive function as
adults), it is important to understand and
consider similarities and differences in repro-
ductive development between the animal
model and humans. The objectives of this
paper are a) to review and discuss key events
in the development ofthe reproductive sys-
tem in animal models and humans (as sum-
marized in Figures 1 and 2); b) to compare
and contrast critical windows in human
reproductive development with analogous
events in experimental animals (where infor-
mation exists); and c) to summarize the major
health outcomes of concern that would be
expected to be associated with exposures dur-
ing the preconceptional, prenatal, and post-
natal developmental windows.
Key Periods in the
Development ofthe
Reproductive System
Preconceptional Period
Animals. In the male, preconceptional expo-
sures are defined as exposures affecting sper-
matogenesis in the adult. With theexponential
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proliferation ofgerm cells during spermato-
genesis, the germ cells make up the majority
ofcells in the testis (1). The production of
spermatozoa is a highly ordered process; the
timing is species and strain specific. In rats,
the process takes 48-52 days, depending on
the strain examined, whereas it takes as few
as 34.5 days in mice and as many as 64 days
in man. The adult testis is the site of the
highest ongoing mitotic cell division in the
body. Spermatogonia undergo several mitotic
divisions (3-6 depending on the species) to
become spermatocytes. Primary spermato-
cytes proceed through prophase, metaphase,
and anaphase; in anaphase the paired chro-
mosomes move to opposite sides ofthe cell.
This differs from mitosis, where it is the sis-
ter chromatids that move to opposite sides of
the cell. In telophase there is incomplete
cytokinesis and the two daughter cells that
result form a syncytium. At the completion
of the first meiotic division, the primary
spermatocyte becomes a secondary spermato-
cyte. There is a short interphase between the
first and second meiotic division when no
DNA synthesis occurs. During the second
division, the secondary spermatocyte pro-
gresses from prophase through telophase; in
anaphase there is separation of the sister
chromatids, similar to mitosis. After the
completion of the second division, the sec-
ondary spermatocytes are called spermatids.
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Figure 1. Critical windows of exposure: the reproductive system.
Thus, one primary spermatocyte gives rise to
four spermatids. The early spermatids are
round cells that undergo a tremendous num-
berofchanges during aprocess called spermio-
genesis: the acrosome is formed, chromatin
condenses, excess cytoplasm is shed, and the
flagellum develops. As germ cells develop, they
move from the periphery ofthe seminiferous
tubule (spermatogonia) toward the lumen
(spermatids and spermatozoa). Spermiation is
the release ofspermatozoa into the lumen.
Manychemicals perturb orarrest this process.
Although the firstwave ofspermatogenesis
is under the control ofboth testosterone and
follicle-stimulating hormone (FSH), the rela-
tive importance ofFSH in maintaining sper-
matogenesis in the adult seems to be highly
species dependent. In most species studied to
date, testosterone, which is normally synthe-
sized in Leydig cells under the influence of
luteinizing hormone (LH), alone can qualita-
tively maintain complete spermatogenesis. In
mice with null mutations for the FSH-,
subunit, only a quantitative reduction in sper-
matogenesis has been noted, with no conse-
quent effect on fertility. Hence testosterone
appears to be the primary regulator ofsper-
matogenesis, although many other factors,
such as insulin-like growth factors, oxytocin,
and transforming growth factor-fB, clearly play
a role in modulatingthis complexprocess.
Spermatozoa are released from the testis
in an immature state (without motility or the
ability to bind to or fertilize an oocyte). The
maturation process takes place in the epididy-
mis during a 5- to 10-day transit period. The
epididymis is responsible for the maturation
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Figure 2. Key developmental events in human reproductive tissue, gland and organ development during the critical windows. EW, embryonic week.
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ofspermatozoa, as a conduit for spermatozoa
to get to the vas deferens, and as a storage
site (2,3). From the first meiotic division
onward, germ cells are outside ofthe central
compartment ofthe body, i.e., they traverse
a blood-testis/blood-epididymis barrier.
Although this barrier allows for the creation
of a special environment that excludes pro-
teins such as immunoglobulins and highly
polar chemicals, it does not prevent the
access ofmanychemicals to the germ cells.
At the time ofejaculation, spermatozoa,
stored in the cauda epididymidis, vas defer-
ens, ampulla, and ejaculatory duct, combine
with secretions from the sex accessory glands
(prostate, seminal vesicles, bulbourethral
gland, and Cowper's gland). These glands
provide the fluid environment for spermato-
zoa. The seminal vesicle provides most ofthe
fluid and some of its components include
ascorbic acid, prostaglandins, fructose, and
clotting factors. Factors secreted by the
prostate include citric acid, acid and alkaline
phosphatases, polyamines, zinc, and various
proteases. The secondary sexual glands and
the epididymis are under the control of
androgens. More specifically, these tissues are
under the control of dihydrotestosterone
(DHT), which is produced when testosterone
is reduced in the 5a position by steroid 4-ene
5a-reductase. It is noteworthy that the pro-
portion ofthe volume ofsemen contributed
by spermatozoa and epididymal secretions is
< 15% in most mammals; hence, most ofthe
seminal volume is derived from the ductal
system ofthe accessory glands. The presence
ofexogenous chemicals in these secretions
may result in exposure ofthe female partner
during mating.
In the female, preconceptional exposures
may affect oocytes as they progress from
their arrested state and begin proceeding
through the primary and secondary follicular
phases to ovulation and fertilization. Little is
known about the intragonadal mechanisms
involved in triggering an arrested primordial
follicle to enter the primary follicle pool,
although it is clear that the pituitary and
higher brain centers are not required. Atresia
is the predominant fate ofprimary follicles.
Ifan oocyte does not undergo atresia, it will
take three to four cycles (depending on the
species) for a follicle entering the pool of
primary follicles to become a Graafian folli-
cle and be ovulated; gonadotropin-releasing
hormone (GnRH), FSH, and LH play sig-
nificant roles in folliculogenesis. The process
ofovulation is carefully timed, and it requires
accurate communication among the hypo-
thalamus, the pituitary, and the ovary (fol-
licular and luteal cells) using an array of
signals. Although exposure to chemicals
occurs during folliculogenesis, ovulation,
oocyte transport, and fertilization, there is
little evidence that any such exposures result
in specific toxic effects on tissues of the
reproductive system.
Humans. In man the complete processes
ofspermatogenesis and sperm maturation are
remarkably similar to those observed in other
mammals, but it takes well over 2 months (64
days for spermatogenesis and 3-10 days for
sperm maturation); the stages ofspermatoge-
nesis are arranged in a helical, as opposed to
linear, arrangement in the seminiferous
tubules. Among mammals, man is one ofthe
species that produces the lowest number of
spermatozoa per gram oftesticular tissue; fur-
thermore, his spermatozoa are oflower qual-
ity (more abnormal forms, fewer motile
sperm, and with lower motility characteris-
tics) than nearly any other mammal. The rea-
sons why sperm production rates and sperm
quality are so relatively poor in humans have
not been established, but factors such as arti-
ficially elevated scrotal temperatures (due to
clothing or certain lifestyles), exposure to tox-
icants, and genetics may play a role.
After sexual maturity in the female,
folliculogenesis leads to a midcycle LH surge
that induces the single follicle destined for
ovulation to undergo events preparing it for
possible fertilization. First, meiosis is
resumed, with the completion of the first
meiotic division and formation ofone daugh-
ter cell and a second smaller cell with little
cellular content, the polar body. The daugh-
ter cell enters into the second meiotic division
and arrests in the second metaphase until fer-
tilization. The follicle becomes highly vascu-
larized and a protrusion in the follicular wall
(macula pellucida) indicates the location of
the rupture, resulting in the release ofthe
oocyte with its surrounding granulosa cells.
Atovulation, the oocyte (with its surrounding
granulosa cells) is extruded onto the ovarian
surface, where the cumulus mass can be
retrieved by the fimbriated end ofthe fallop-
ian tube. After ovulation, the walls ofthe fol-
licular cavity in the ovary develop into the
corpus luteum. If fertilization occurs, the
lifespan ofthe corpus luteum is prolonged;
otherwise, it disintegrates during the 14 days
ofthe luteal phase ofthe menstrual cycle.
In addition to triggering ovulation, the
midcycle LH surge induces luteinization of
the theca and granulosa cells of the follicle
wall. Normal luteal function depends on both
normal folliculogenesis and successful follicu-
lar rupture. Vascularization ofthe follicle wall
that occurs with ovulation provides the
luteinized theca and granulosa cells with low-
density lipoprotein cholesterol from the
circulation, which is used to synthesize
progesterone. Follicular growth, ovulation,
and maintenance ofpregnancy are controlled
by the balanced secretion of FSH and LH.
Both hormones act on the ovarian target cells
by means ofcell surface receptors. In addition,
FSH stimulates the aromatization oftheca-
derived androgens to estrogens by granulosa
cells. The main endocrine action ofLH is to
stimulate progesterone production by granu-
losa cells. LH stimulation also induces follicu-
lar theca cells and stromal interstitial cells to
produce androgens, which serve as precursors
for FSH-dependent estrogen production by
granulosa cells.
Prenatl Period
Animals. Chromosomal sex is determined at
fertilization. The presently accepted hypothe-
sis is that genetic sex is dependent on a gene
on the Y chromosome, designated Sry (sex-
determining region-Y-chromosome) [reviewed
by Parker et al. (4)]. Szy has a DNA-binding
motif termed the high-mobility group
(HMG) box. SOX(homologous to Sry HMG
box) genes have > 60% homology with Sry,
one SOXgene, SOX9, is also involved in sex
determination. The orphan nuclear receptor
steroidogenic factor 1 (SF-i) regulates the
expression ofmany genes involved in steroido-
genesis, as well as the expression ofMullerian-
inhibiting substance [(MIS) from Sertoli cells]
[reviewed by Parker et al. (4)]. SF-1 is required
for the development oftestes and male sexual
differentiation but may suppress ovarian devel-
opment and female sexual differentiation.
Other genes that are involved in sex determi-
nation indude a tumor-suppressor gene, WVTI,
and a gene designated DAX-1 (dosage-sensitive
sex reversal, x-linked). DAX-1 and SF-i may
act in the same pathway.
Many of the critical steps in the forma-
tion of the reproductive system take place
during embryogenesis. Establishment of the
primordial germ cell lineage occurs early
during development and is regulated by spe-
cific transcription factors and growth factors
such as Oct-4 or Bmp-4 (5,6). In mam-
malian embryos, it remains unclear as to
which specific inner cell mass cells in the
blastocyst are specified to become germ cells.
Initial gonadal formation involves the estab-
lishment of a primordial germ-cell lineage
and the migration of these primordial germ
cells to embryonic mesoderm of the primi-
tive streak. Migrating germ cells move from
the visceral endoderm ofthe yolk sac to the
developing hindgut, through the dorsal
mesentery, to finally reach the gonads. In
the mouse on gestation day (GD) 8, 10-100
primordial germ cells can be identified; by
GD 13, the gonads contain 10,000 germ
cells [reviewed by Byskov and Hoyer (7)].
The number of primordial germ cells
depends on their mitotic activity; from GD
8.5-13.5 in the mouse, primordial germ
cells replicate by mitosis at a uniform rate
and in a similar manner in both males and
females. Although some species have a
Environmental Health Perspectives * Vol 108, Supplement 3 * June 2000 493PRYOR ETAL.
period oflow mitotic activity, in others it is
very short (rat) or nonexistent (mouse). The
proliferative phases preceding meiosis are
extremely sensitive to exposure to irradiation.
Sexual differentiation, or the establish-
ment ofa male or female sexual phenotype,
occurs either during organogenesis or during
the fetal period. Initially, the gonads are in an
indifferent stage and the urogenital tracts of
the male and female are indistinguishable.
The time window during which gonadal sex
can be influenced in vitro in the mouse is
from GD 10-12.5 (7). SF-i plays a key role
in sexual differentiation by regulating the syn-
thesis and secretion ofsteroids and other mor-
phogenetic substances that exert a major effect
on the phenotype ofthe embryo. The bipo-
tential gonad will differentiate in the male
into a testis, with cordlike structures, and in
the female into an ovary. Once sexual differ-
entiation is initiated (at approximately GD
13.5 in the mouse), the subsequent kinetics of
development are dramatically different in the
male and female.
Testicular cords are formed in the differ-
entiating testis; these contain germ cells that
are in close approximation to somatic cells,
which are the precursors to Sertoli cells. Germ
cells enclosed in testicular cords are called
prospermatogonia. In the fetal testis, prosper-
matogonia undergo waves ofmitosis and mor-
phological differentiation before a transient
arrest in interphase (G1) on GD 18 in the rat.
Mitotic divisions are reinitiated just before
birth. Sertoli cells proliferate throughout fetal
development; their highest proliferative activ-
ity is on GD 16 in the fetal rat. The destruc-
tion ofSertoli cells or interference with their
proliferation may have irreversible effects on
the development ofthe testis and its potential
to produce sperm during adulthood. In the
rat, testosterone synthesis starts simultane-
ouslywith the differentiation ofLeydigcells at
the fetal age of 15.5-16.5 days; LH receptors
appear at 15.5 days. Leydig cells proliferate
slowly during early stages ofdifferentiation.
Steroidogenesis is one potential target for
chemical action. Insufficient androgen will
result in feminization ofthe testis, resulting in
a gonad that lacks testicular cords. Testicular
steroids are responsible for maintenance and
differentiation ofthe internal (testosterone)
and external (dihydrotestosterone) genitalia,
and for priming the brain in the male direc-
tion atearlydevelopmental stages (8).
In the absence oftesticular hormones, the
pathway ofsexual differentiation in mam-
mals is female [reviewed by Byskov and
H0yer (7)]. In the rodent fetal ovary, germ
cells continue to undergo mitosis until they
enter meiosis; the first germ cells to enter
meiosis are localized in the inner part ofthe
cortex. Meiosis is arrested in the late
prophase of the first meiotic division, the
diplotene stage, at which time follicles begin
to form. To survive beyond the diplotene
stage, oocytes must be enclosed in a follicle
together with supporting granulosa cells; a
large percentage of the oocytes that enter
meiosis do not reach the diplotene stage, but
instead degenerate. In some species, such as
mice and ratswith immediate meiosis, ovarian
steroidogenesis does not take place until after
follicles are formed. MIS, which is secreted by
Sertoli cells in the testis, can induce the for-
mation of structures resembling testicular
cords in the fetal ovary. Gametogenesis in the
female may be especially sensitive to prenatal
chemical exposures.
Genomic imprinting distinguishes genes
as functionally nonequivalent on the basis of
the parent oforigin. Imprinting is an epige-
netic mechanism by which the expression of
certain genes (some 30 in humans and mice to
date) becomes dependent on their parent of
origin. Imprinted genes play key roles in
growth and differentiation; the maternal and
paternal genomes are both essential for normal
embryo development to occur. One epigentic
feature that is consistently associated with
imprinting is CpG methylation. Genomic
imprints are erased during earlyembryo devel-
opment and must be reestablished in germ
cells during gametogenesis (9,10), making
imprinting a potential target in gametes for
toxicant action.
In the male, under the influence of
testosterone from the Leydig cells, the
Wolffian ducts differentiate into the epi-
didymides, vas deferens, ejaculatory ducts,
and seminal vesicles. Sertoli cells secrete
MIS, which causes the Mullerian ducts to
regress. Both testosterone and MIS are regu-
lated by SF-1. In the female fetus, where
there is an absence oftestosterone and MIS
(MIS secretion is not detected in the ovary
until postnatal day 6 in the mouse), the
Mullerian ducts differentiate into the
oviducts, Fallopian tubes, uterus, and upper
vagina, while the Wolffian ducts regress.
Estrogen receptors are present in the
Mullerian ducts in the mouse as early as day
15 of fetal life. The effect of MIS on the
Miillerian ducts in the male can be prevented
byexogenous estrogens. Wolffian duct differ-
entiation is dependent on testosterone,
whereas DHT, the 5a-reduced androgen,
appears to be responsible for the differentia-
tion of external genitalia in the fetus.
Exposure to androgens will masculinize the
female external genitalia. Other signaling
molecules are also important in genital duct
development. Hoxa-10, a developmentally
important signaling molecule, is maximally
expressed in the Wolffian duct and urogeni-
tal sinus in the day 18 mouse fetus; loss of
Hoxa-10 function is associated with dimin-
ished stromal clefting ofthe seminal vesicles
and decreased size and branching of the
coagulating gland (11). Signaling by Wnt-7a
appears to be involved in the sexually dimor-
phicdevelopment ofthe Mullerian ducts (12).
Humans. The conceptus is properly
called an embryo from the time the bilaminar
germ layer appears during the second week
after fertilization to approximately the eighth
week ofgestation, by which time most major
organ and tissue development has occurred.
By the end ofthe embryonic period in the
eighth week, tissues and organ systems have
developed and the major features ofthe exter-
nal body form have developed. The period of
development between the fourth and the
eighth week, when all ofthe major tissue and
organ systems begin to develop in the human
embryo, is referred to as organogenesis. The
fetal period extends from the ninth week
until birth. During the fetal period, the fetus
grows in weight from approximately 8 g to
approximately 3,400 g. Weight is gained
mainly in the third trimester, but the fetus
increases in length mainly during the second
trimester. Many organ systems, including the
brain, peripheral nervous system, sensory
systems, and the reproductive system, are not
mature at birth.
There are striking similarities between
the differentiation of the human reproduc-
tive tract and that ofother mammals. The
genital system arises in close conjunction
with the urinary system; the primitive sex
cords develop from cells ofthe mesonephros
and coelomic epithelium that proliferate to
form the genital ridges. Until the end ofthe
sixth week, the male and female genital sys-
tems are virtually identical. Cortical and
medullary sex cords and mesonephric and
paramesonephric ducts are present in both
sexes. This period is called the ambisexual
(indifferent) phase ofsexual development. In
the sixth week a new pair ofducts, the para-
mesonephric (Mullerian) ducts, develop
adjacent to the mesonephric ducts. The para-
mesonephric ducts have separate fates in the
two sexes, and starting in the seventh week,
the sexes diverge as the primitive sex cords
pursue these separate fates. Germ cells from
the yolk sac endoderm migrate along the
dorsal mesentery of the hindgut to the
gonadal ridge in approximately the sixth
week ofgestation.
Under the influence oftestis-determining
factor from the Sry gene, the primary sex
cords differentiate into seminiferous tubules
and the indifferent gonad develops into a
testis. Sertoli cells are thought to develop
from mesenchymal cells or mesonephrogenic
blastema (13). The Sertoli cells surround the
germ cells to form testicular cords (14). MIS
plays a similar role in man as it does in other
mammals, i.e., inhibition ofthe development
of the Mullerian (paramesonephric) ducts;
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without MIS, the Miillerian ducts would
develop into the female reproductive system.
Leydig cells develop from mesenchymal
cells in the testicular interstitium beginning at
8 weeks ofgestation (15); these cells are stim-
ulated by human chorionic gonadotropin to
secrete testosterone beginning at approxi-
mately 8 weeks of gestation. At around 12
weeks of gestation, LH levels begin to rise
and it is thought that the fetal pituitary
begins to take over control of Leydig cell
function (16). Serum testosterone peaks at
approximately 14 weeks ofgestation and after
24 weeks declines to female levels (17).
As in the male, the female primordial
germ cells undergo mitotic division in the
yolk sac until the time ofgonadal differentia-
tion (7). The migration ofprimordial germ
cells into the gonadal ridge is complete by 7
weeks ofgestation. The gonadal ridge grows
and surrounds the primordial germ cells, and
together they form the surface epithelium, the
primitive cords, and the gonadal blastema.
Gametogenesis begins during fetal life in
females (oogenesis) but is suspended at an
early stage and does not resume until after
puberty. Female gonads begin to differentiate
approximately 8 weeks after fertilization; this
is about 1 week later than in males. The
gonadal blastema begins to differentiate into
medullary cords and stroma; the medullary
cords mostly degenerate, whereas the cortex is
preserved. The early ovarian cortex contains
oogonia and epithelial cells. By the eleventh
week offetal life, interstitial connective tissues
(stroma) intersect the epithelium leading to
compartments containing single oocytes sur-
rounded by a single layer ofepithelial cells
(primordial follicles). The ovaries descend into
the pelvis by the twelfth weekoffetal life.
Oogonia are transformed into oocytes by
the initiation of meiotic division during the
third to ninth months of fetal life. All of the
oocytes a female will produce are present in
the ovaries by 5 months offetal life, at which
time approximately 7 million primordial folli-
cles have formed. This number is reduced by
atresia to about 2 million by birth and 0.5
million by puberty. As in other mammals, in
human fetal oocytes, meiosis proceeds only to
the first meiotic prophase and then enters a
stage of arrest in the diplotene stage of the
first meiotic prophase.
The female phenotype is the default; it is
generally believed that no additional factors
are required for the development of female
gametes and sexual characteristics. In the
absence ofMIS, the paramesonephric ducts
give rise to the oviducts, uterus, and superior
vagina. The caudal vagina forms from the
posterior wall ofthe pelvic urethra. The cau-
dal portions of the paramesonephric ducts
fuse together to form a tube, the uterovaginal
(genital) canal, which differentiates into the
uterus and the superior segment of the
vagina. The cranial unfused segments of the
paramesonephric ducts become the oviducts
(fallopian tubes).
The early phases ofexternal genital devel-
opment are similar in the two sexes, and the
sexes generally become distinct during the
fourth month ofgestation. As in other mam-
mals, DHT induces male differentiation of
the external genitalia, whereas female develop-
ment occurs in its absence. The first step in
external genital development is the appearance
of a pair ofcloacal folds on either side ofthe
cloacal membrane. The fusion ofthe urorectal
septum with the cloacal membrane in the sev-
enth week creates the perineum. The urorectal
septum also subdivides the cloacal folds into
ventral urethral (urogenital and genital) folds
and dorsal anal folds. A new pair of broad
swellings, the labioscrotal swellings, develop
laterally into the urethral folds. The urogenital
membrane becomes patent in the seventh
week. The genital tubercle elongates to form
the phallus, which is divided by a coronary
sulcus into a glans and a shaft. In the male,
the scrotal swellings fuse in the midline to
form the scrotum. In the female the labioscro-
tal swellings and urethral folds do not fuse.
The labioscrotal swellings become the labia
majora and the urethral folds become the labia
minora. The testes and ovaries both descend
under the control ofa gubernaculum, which is
a ligament that condenses within the sub-
serous fascia during the seventh week.
Testicular descent into the scrotum is proba-
bly under the control ofboth androgens and
mechanical processes (14,18).
The mammary glands are modified apoc-
rine glands that arise along mammary ridges
on either side ofthe body. A pair ofectoder-
mal thickenings called mammary ridges
appears on the ventral surface in the fourth
week ofgestation. In the fifth week the mam-
mary ridge at the site of each presumptive
breast forms the primary bud ofthe mammary
gland. In the tenth week these buds branch to
form several secondary buds that then
lengthen, branch, and canalize during the
remainder ofgestation to form 15-25 lactifer-
ous ducts. At birth the lactiferous ducts ofeach
mammary gland open into a superficial depres-
sion called the mammary pit, which is usually
converted to a raised nipple within the first
weeks after birth. It is speculated that the
number ofestrogen receptors in mammary tis-
sue is determined at this stage and that this
predisposes the breast for responses to environ-
mental insults during adulthood, and thus pos-
sibly estrogen-dependent breast cancer. Hence,
mammary bud formation is proposed to be a
critical window for normal development and
adult function.
GnRH release from the hypothalamus
influences LH and FSH production by the
pituitary gland beginning in fetal life. The
mean peak plasma levels ofLH and FSH dur-
ing gestation are higher in female than in
male fetuses. The pulsatile release ofLH and
FSH secretion is controlled by neurons
located in the arcuate nucleus of the hypo-
thalamus, which secrete GnRH into the
hypothalamic-hypophysial portal system.
Postnatal Period
Animals. In the male there are rapid mitotic
divisions of both spermatogonia and Sertoli
cells in the first few days after birth. Although
some spermatogonia undergo mitotic divi-
sions before the initiation of meiosis to even-
tually become spermatozoa, others continue
to divide so that a pool ofstem cells is main-
tained. New waves ofspermatogenesis are ini-
tiated on an ongoing basis. In the rat, Sertoli
cells stop dividing at the beginning of the
third postnatal week and form tight junctions
between adjacent cells, constituting the
blood-testis barrier. After spermatogonia
enter meiosis, they cross the barrier by a zip-
perlike action to enter the adluminal com-
partment. The last round of DNA synthesis
occurs just before the first meiotic division.
Thereafter RNA synthesis continues in sper-
matocytes and round spermatids but ceases as
the sperm chromatin condenses in the final
stage of spermiogenesis. Some of the RNAs
produced in round spermatids are not trans-
lated until later in spermiogenesis. Instead
these RNAs are bound to proteins (such as
testis brain RNA-binding protein or p48/52);
it has been suggested that germ-cell-specific
mRNA-protein binding has a role in the sta-
bilization and subsequent translation of tran-
scripts throughout spermiogenesis (19,20).
For any given species, there is a fixed ratio of
Sertoli to germ cells; thus, agents that affect
Sertoli cell proliferation during the first 2
weeks of postnatal life will set the sperm
production rate per testis.
The neonatal hormone environment
profoundly affects the ultimate sexually dif-
ferentiated pattern of central nervous system
(CNS) anatomy and neurochemistry, repro-
ductive physiology, and behavior. Sexual dif-
ferentiation ofthe CNS depends on exposure
to gonadal steroid hormones (21-23).
Morphological differences between the sexes
have been shown at the light microscopic and
ultrastructural levels in several nuclear regions
of the CNS (24). Neonatal androgenization
of female rats produces a diminished LH
secretory pattern that is characteristic ofmales
(25). Such androgenization results in delayed
onset ofpuberty, decreased regularity ofovar-
ian cyclicity, and cessation of cyclicity at an
earlier age (26-28).
Sexually distinctive differences in patterns
ofbehavior can be affected by perinatal expo-
sure to gonadal steroids (29). Estrogen, and
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to a lesser extent progesterone, act in the
CNS to control lordosis behavior in rats. In
female nonhuman primates, attractivity and
proceptivity change with the stage of the
menstrual cycle or as a result ofsex steroid
administration. The effects ofhormones on
receptivity are unclear. The lordosis response
is diminished by androgenization. Other
behaviors that showsuch sexuallydistinct dif-
ferences include aggressive behavior, social
play and open field behaviors, territorial
marking, urination posturing, regulation of
food intake, taste preference, and tests of
performance andlearning (21,22).
Studies ofmale mating behavior have been
conducted in a variety ofmammalian species.
The repertoire ofmale mating involves pre-
copulatory behavior, mounting, intromission,
ejaculation, and postejaculatory behavior. In
rodents, male sexual behavior is dependent on
the production ofestradiol from testosterone
in specific brain nuclei. Important aspects of
male mating behavior are controlled by the
preoptic anterior hypothalamic area. Rhesus
monkeys with bilateral lesions in this area do
not attempt to copulate but continue to mas-
turbate and achieve erections, indicating a
deficit in mating behavior toward the female
but with no obvious neuroendocrine physio-
logical compromise (30).
Humans. Spermatogonia are the only
germ cells present in the prepubertal testis,
although there are reports ofsome prelep-
totene spermatocytes being present (31).
Between birth and 10 years ofage, there is a
6-fold increase in the number ofspermatogo-
nia; this occurs by mitotic division (14,32). At
puberty there is an exponential increase in
both the number ofgerm cells and the testicu-
larvolume (14). Immature Sertoli cells are the
most common somatic cell type seen in the
prepubertal testis (14). The total number of
Sertoli cells increases in the prepubertal period
and into early adulthood (14,33).
There is a postnatal rise in serum testos-
terone that occurs at approximately 3 months
ofage (34). It is not surprising, then, that
there is a biphasic pattern of Leydig cell
developmentwith a nadir oftestosterone con-
taining cells at approximately 1.5 years ofage
(16). The number oftestosterone-producing
Leydig cells progressively increases with time
until itplateaus at adulthood.
Spermatogenesis is designed to generate
haploid cells by reduction division and to
increase genetic variation (3). Spermarche,
defined as the age at which spermatogenesis
begins, occurs early in puberty. The mean age
ofspermarche istypicallydetermined bynoting
sperm in the urine collected from boys. In one
longitudinal study the mean age ofspermarche
was 13.4 years, and ranged from 11.7 to 15.3
years (35). Adult levels oftestosterone do not
occuruntil 2yearsafterspermarche(36).
Because LH and FSH are involved in
regulating spermatogenesis, the control of
their pituitary release by the hypothalamus is
important in maintaining testicular function.
During puberty, inhibin, produced by Sertoli
cells, is the major factor involved in the feed-
back inhibition ofFSH. Testosterone exerts a
negative feedback on GnRH release from the
hypothalamus and is thus involved in the reg-
ulation ofboth LH and FSH secretion. Males
release LH from the pituitary in a pulsatile
manner, and this induces increases in circulat-
ing testosterone. Because ofits longer half-life,
the circulating levels ofFSH exhibit little pul-
satility. Neonatal exposure ofthe hypothala-
mus to androgen is necessary for the sexual
differentiation ofthe LH secretory mechanism
to respond to either androgen orestrogen.
In the newborn female, oocytes are
enclosed within primordial follicles and are
arrested in the diplotene phase ofthe first
meiotic division. They remain in this condi-
tion until puberty; menarche is the beginning
of menstrual function. Throughout post-
pubertal life, cohorts offollicles continue to
be recruited. Some ofthese will mature to
become Graafian follicles, with consequent
ovulation; however, most follicles undergo
atresia. Although approximately 2 million fol-
licles are present at birth, essentially all are
depleted by about 50 years ofage, resulting in
menopause. Phasic entry ofcohorts offolli-
cles into further folliculogenesis establishes
menstrual cyclicity. During each menstrual
cycle, only one oocyte ofthe cohort usually
progresses to ovulation and to potential
resumption ofmeiosis iffertilization occurs.
Follicular growth, ovulation, and mainte-
nance ofpregnancy are controlled by the bal-
anced secretion ofLH and FSH. The main
actions ofLH are to trigger follicular rupture
and oocyte release, to stimulate progesterone
production by granulosa cells, and to stimu-
late follicular theca and stromal interstitial
cells to produce androgens. FSH stimulates
follicular growth and the aromatization of
theca-derived androgens to estrogens by gran-
ulosa cells. LH secretion in prepubertal
females occurs in a basal fashion with irregular
pulsatile occurrences. In cycling females, the
ovarian steroid and pituitary profiles are inti-
matelylinked to produce the menstrual cycle.
Events occurring around puberty instigate
the start of mating behavior. At puberty,
males and females become aware of each
other as sexual beings. Experience and hor-
mones are important in the maintenance of
copulatory behavior. In human males and
females, androgen increases libido. Women
treated with androgens frequently complain
ofexcessive libido as a side effect, whereas
women treated with antiandrogens complain
ofreduced libido. Sexual activity may occur
when testosterone levels are relatively low,
although an interval oftestosterone priming
may be necessary. Stress reduces plasma
testosterone in males and females by acting
through the hypothalamic-gonadal axis;
stress-induced depressed hypothalamic func-
tion affects both male and female mating
behavior, decreasing and even eliminating it
in some cases.
Environmental influences on reproduc-
tive function and mating behavior may
occur through visual and olfactory cues. For
example, circadian rhythms influence the
timing ofthe periovulatory surge ofLH and
ovulatory rates. The LH surge tends to occur
at night and in the morning (37,38). The
best evidence ofseasonal variation in human
reproduction is from studies with Alaskan
Eskimos, showing seasonal changes in birth
rates corresponding to peaks in June and
January (39). Humans do not reproduce in a
rigidly seasonal manner, possiblybecause they
have a reduced ability to respond to environ-
mental cues or because they live in modified
environments that attenuate the impact of
such cues (40).
Macaques, which are seasonal breeders in
temperate environments, will ovulate year-
round when housed in conditions ofcon-
trolled temperature and light (40,41).
However, macaques that are reared indoors
and exposed to varying photoperiods show
the expected pseudoseasonal variation in
ovulatory pattern, as ifthey were still housed
outdoors; they do not lose their ability to
ovulate year-round ifthen placed in a fixed
photoperiod regime. This suggests that
humans no longer demonstrate a reproduc-
tive response to changing photoperiods
because ofontogenic and possibly evolution-
ary experience. Pheromones also may play
important roles in human reproduction.
However, the only confirmed pheromone-
driven reproduction phenomenon is men-
strual cycle synchronicity in females sharing
the same living environment (40,42,43).
Until puberty, the mammary glands of
males and females are essentially the same. In
the female, the increase in estrogen levels at
puberty resulting from pulsatile secretion of
gonadotropins stimulates growth ofthe rudi-
mentary mammary gland. When progesterone
production starts as part ofan ovulatory cycle,
it stimulates the alveolar buds within the
mammary lobules. After puberty, the chang-
ing estrogen and progesterone levels in the
cycling female affect breast tissue develop-
ment, with maximal activity in the luteal
phase. Because the levels ofestrogen and prog-
esterone in the cycling female are under the
influence of the hypothalamo-pituitary axis,
the neuroendocrine system indirectly influ-
ences breast development. The mammary
alveoli do not fully develop until pregnancy
and lactation. Cortisol, insulin, and placental
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lactogen contribute to alveolar development,
but estrogen and progesterone are most
important. During pregnancy, estrogen and
progesterone cause the mammary gland ductal
system to undergo further branching, and the
alveolar cells undergo proliferation.
Health Outcomes of Exposure
Preconceptional Exposures
Animals. Because germ cells in the male are
being generated continuously, treatment of
adult males with radiation or with cytotoxic
chemicals such as lead, ethylnitrosourea, or
urethane or drugs such as cyclophosphamide
can produce adverse effects on fertility and on
progeny, with outcomes ranging from pre-
and postimplantation loss (dominant lethal-
ity) to growth retardation and malformations
(44,45). Exposure of the postmeiotic male
germ cell to chemicals such as cyclophos-
phamide can also induce learning abnormali-
ties in the progeny (46). The parameters that
exposures may affect include the number of
spermatozoa (producing oligospermia or
azoospermia), and their motility, morphol-
ogy, or nuclear/chromatin structure (47).
Other chemicals may adversely affect progeny
outcome without any apparent effects on
sperm numbers, motility, or external parame-
ters ofthe male reproductive system itself.
The susceptibility ofgerm cells through-
out spermatogenesis and epididymal sperm
maturation to toxic chemicals is often chemi-
cal and/or stage specific; the susceptible stage
can be assessed by the lag time between drug
exposure and the effect on spermatozoa. Post-
testicular damage to spermatozoa by chemical
agents can occur during epididymal transit.
For example, exposure of rats to cyclophos-
phamide for 4-7 days before conception, or
after ligation ofthe efferent ducts, results in a
marked increase in postimplantation loss (48).
Ethylnitrosourea exposure of spermatozoa
during epididymal transit also results in a high
frequency ofembryo death (dominant lethal-
ity) in the offspring oftreated mice (49).
Germ cells that have completed their
divisions and are differentiating (spermatids)
seem to be particularly sensitive to agents
that damage chromatin; this may be related
to a loss of many of the enzymes associated
with DNA repair during the later stages of
spermatogenesis (50). For example, after
exposure of mice to chlorambucil, a peak in
mutation yield is observed when offspring
are conceived from germ cells exposed as
spermatids (exposure 10-18 days before con-
ception) (49). Similarly, exposure to
cyclophosphamide while germ cells are going
through spermiogenesis results in dramatic
increases in postimplantation loss (51).
Germ cells at the spermarogonial stage are
particularly susceptible to X-ray exposure in
both mice and man (longer exposures, 35
days or more before conception) (52).
In rats, the increase in postimplantation
loss found after chronic low-dose exposure
of the fathers to cyclophosphamide was
reversed within 4 weeks of the termination
of drug treatment (53); thus, cyclophos-
phamide-induced postimplantation loss was
associated primarily with germ cell exposure
during spermiogenesis. Presumably this
reversibility occurred because the stem cells
that were exposed either had the ability to
repair the damage caused by alkylating drugs
or died by apoptosis. In contrast, exposure
to agents that result in more dramatic dam-
age to stem cell nuclei, e.g., procarbazine,
which causes sister chromatid exchange, had
effects that were poorly reversible (54). The
data that are available on the reversibility of
the effects on spermatogenesis ofexposure of
men to anticancer drugs suggests that reversal
in humans, at least with respect to effects on
numbers ofsperm in the ejaculate, may take
years. The extent to which stem cells are
affected is critical. It has been estimated that
men are approximately 3 times more sensi-
tive to the stem-cell-killing effects of radia-
tion than mice (52).
The male genome is a focus for studies on
the mechanism of the effects of paternal
exposure to toxicants such as cyclophos-
phamide on progeny outcome, largely
because such drugs interact with chromatin
and some of their effects are transmitted to
the F2 generation (55). In rats it has been
demonstrated that paternal exposure to drugs
like cyclophosphamide damages male germ
cells in such a manner that chromatin remod-
eling of the male genome is disrupted in the
zygote, resulting in altered zygotic gene acti-
vation and embryo death (56). Another
mechanism by which toxicants may affect
germ cells leading to a disturbance in progeny
development is disruption of the genomic
imprinting ofparental germ cells. An example
ofsuch a chemical exposure may be 5-azacyti-
dine. The incorporation of5-azacytidine into
DNA prevents the 5' methylation ofcytosine
by DNA methyltransferase, inhibiting the
usual hypermethylation ofsperm DNA. The
chronic exposure ofmale rats to 5-azacytidine
results in oligospermia and azoospermia as
well as enhanced preimplantation loss among
the offspring (57).
As an alternative to a direct effect on
germ cells, preconceptional paternal expo-
sures may adversely affect progeny outcome
via the presence ofchemicals in the seminal
fluid. Many drugs are well absorbed after
intravaginal administration. Thus, a drug in
the seminal fluid may be absorbed and dis-
tributed throughout the female, and affect
fertilization of the oocyte. There are drugs
(methadone, morphine, thalidomide, and
cyclophosphamide) that have been reported
to adversely affect progeny outcome by this
type of mechanism on the basis of animal
experiments (45,58-60). We speculate that
the presence of a chemical in the seminal
fluid may affect the completion of meiosis in
the oocyte or male pronuclear formation in
the fertilized zygote. One study demonstrated
that the exposure ofpig oocytes for 48 hr in
culture to cyclophosphamide inhibited mei-
otic maturation (61). Unlike most mammals,
humans may continue to have intercourse
throughout pregnancy; hence, the conceptus
may be exposed to a drug in the seminal fluid
not only at the time ofconception, but also at
subsequent times during development. As a
consequence, it is possible that animal experi-
mentation underestimates the potential risk
ofdrugs in semen to progeny outcome.
Relative to the male, few studies have
been done to determine the effects of mater-
nal drug exposure before conception on prog-
eny outcome. A number of oocyte toxicants
can induce aneuploidy with exposures around
the time ofoocyte maturation, ovulation, or
fertilization (62). Exposure of oocytes to a
chemical that is administered to the mother,
or via the seminal fluid, may affect oocyte
maturation and function. In a study in mice,
the exposure ofoocytes to X-rays 1-4 weeks
before ovulation resulted in an increased inci-
dence ofembryolethality, growth retardation,
and malformations (gastroschises) among the
offspring (63). It may be significant that these
manifestations ofdevelopmental toxicity are
similar to those that have been reported after
exposure of the male gamete to a DNA-
damaging agent (51,55). Disruption of the
maternal or paternal parental genome may
result in similar disturbances in zygotic gene
activation, and thus in abnormal embryo
development. Although immature (arrested)
oocytes have been generally considered resis-
tant to induced genetic damage, some studies
with young female mice have shown that sig-
nificant chromosome damage can be caused
by y-irradiation. The administration of high
doses of cyclophosphamide affects mostly
primordial follicles (64). Other potential tar-
gets for chemical insult in the mother
include ovulation, transport of the ovum,
and neuroendocrine regulation ofovulation.
Humans. There is relatively little infor-
mation on the effects ofpreconception expo-
sure to environmental toxicants on human
reproduction. Not surprisingly, much of the
information available is derived from patients
receiving chemotherapy or radiation therapy
for treatment ofcancer.
Toxicants may affect fertility by decreasing
the production of germ cells in the testis,
resulting in azoospermia or oligospermia. The
sensitivity of the testis to cytotoxic therapies
that decrease sperm numbers is proportional
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to the relative proliferation ofthese cells (65).
Sertoli and Leydig cells do not proliferate in
the adult and therefore survive many cyto-
toxic therapies. Ofthe germ cells, spermato-
gonia are the most proliferative and are very
susceptible to apoptosis induced by cytotoxic
therapy. Spermatocytes and spermatids are
relatively insensitive to cytotoxic agents (66).
This is evidenced by the maintenance ofrela-
tively normal sperm counts for the first 2
months of cytotoxic therapy. After 2-3
months oftherapy, the counts often decrease
significantly, corresponding to the effects on
spermatogonia, which in the 2- to 3-month
interval will have become spermatozoa (67).
Ifstem cells survive and differentiate, sperm
production can recur. Often this takes 1 or 2
years after cytotoxic insult (52).
Genetic damage ofthe male germ cell is
ofconcern because this damage can be trans-
mitted to the next generation. That cytotoxic
therapy can cause genetic damage in the ger-
minal cells was demonstrated by fluorescence
in situ hybridization analysis ofmen treated
for Hodgkin's disease with novanthrone,
oncovin, vinblastine, and prednisone chemo-
therapy (68). Aneuploidy ofautosomal and
sex chromosomes was shown in sperm of
these patients, but the effects were transient
and declined to pretreatment levels approxi-
mately 100 days after therapy. Therefore,
risks for chromosomal damage were highest
within one spermatogenic cycle (3 months)
after the male was exposed to cytotoxic
agents. Typically patients are counseled not
to attempt a pregnancy until 6 months after
therapy (66). A few studies have examined
progeny outcome after treatment of the
father with anticancer drugs or radiation
therapy. In cases where exposed men have
been able to father children, the limited data
currently available have not shown an
increased risk ofbirth defects or genetic dis-
ease after chemotherapy or radiation therapy
(66,69). However, at present it is still diffi-
cult to assess the impact ofthe treatment of
men with anticancer drugs on their offspring
because the number of patients in most
studies is low. Interestingly, no significant
increase in genetic damage has been reported
among 30,000 offspring ofparents exposed
to atomic bomb radiation inJapan (70).
The list ofindustrial chemicals thought to
affect the reproductive capacity of human
males includes carbon disulfide, dibro-
mochloropropane (DBCP), and lead (71);
DBCP is perhaps the most widely cited
example ofa man-made chemical that affects
spermatogenesis. In men occupationally
exposed to DBCP, spermatogenesis was
either halted or severely compromised.
Intervention was successful for some men,
with resumption ofnormal spermatogenesis,
whereas others with either higher exposure or
exposure over a longer time frame remained
azoospermic (72). Dose-related disturbances
in spermatogenesis resulting in abnormal
sperm morphology and associated with infer-
tility have been found among men with occu-
pational lead exposures (73). Exposure to a
chlorinated hydrocarbon insecticide, chlorde-
cone (kepone) has also been associated with
oligospermia and altered sperm motility (74).
Hence, human spermatogenesis is a sensitive
target for man-made chemicals; ifexposure is
identified and eliminated, or reduced below a
threshold effect level, then the effects on
spermatogenesis maybe reversible.
To date there is little evidence in the liter-
ature to suggest that preconceptional expo-
sures ofthe mother will adversely affect the
development or function ofthe reproductive
system in her children.
Prenatal Exposures
Animal. During the first part ofthe prenatal
period (from fertilization to gonadal ridge
development), we know ofno specific expo-
sures associated selectively with deleterious
effects on the reproductive system. In both
sexes the establishment ofthe germ stem cell
population in the gonads, as well as differen-
tiation ofthe urogenital system, occur during
the second partofprenatal development.
Cytotoxic drugs may affect mitosis in
early germ cells in either the male or female
fetus. The radiosensitivity ofgonocytes in the
fetal mouse testis increased from GD 14-18
(75). In the male mouse, the period of pri-
mordial germ cell migration (embryonic day
10) was the critical period for disturbance of
postnatal testicular development and fertility
after exposure to ethylnitrosourea (76).
Exposure of the female rodent embryo or
fetus to environmental agents such as ionizing
radiation (77) and glycol ethers (78) depleted
the pool ofprimordial follicles and thus signif-
icantly shortened the reproductive life span.
Exposure ofthe female embryo to cyclophos-
phamide on GD 13 resulted in an increase in
oogonia on GD 17, with lesions ofthe synap-
tonemal complex, such as partial synapsis and
desynaptic bivalents (79). Because oocytes
cannot be replaced or repaired, the outcome
of germ cell death in the female may be
premature reproductive senescence.
One ofthe main mechanisms by which
chemicals alter sexual differentiation is bydys-
regulating sex steroid signaling pathways.
Clearly, chemicals with endocrine-disrupting
activity have profound and predictable effects
on the development ofthe reproductive sys-
tem [reviewed by Barlow et al. (80)]. The
most extensively studied compounds are those
with estrogenic activity. In the female mouse
reproductive tract there are estradiol receptors
in the Mullerian duct from day 15 offetal life
(81). In utero exposure (GD 9-16 in the
mouse) to diethylstilbestrol (DES), the most
widely studied synthetic estrogen agonist,
resulted in malformations and adverse func-
tional alterations in both the male and female
reproductive tract and in the brain (82). DES
seems to prevent total regression of the
Wolffian duct in the female and results in per-
sistence ofMullerian ducts in DES-exposed
males. A high proportion of male mice
exposed prenatally to DES were sterile and
had epididymal cysts, undescended testes, and
nodular lesions in the accessory sex glands
(83). Although the mechanism bywhich DES
disrupts development ofthe reproductive tract
is still not defined, it is interesting that DES
has been reported to down-regulate the
expression of Wnt7a (84,85) and ofHoxa-10
(86); fetal exposure to DES resulted in dereg-
ulation of Wnt7a and of Hoxa-lO in the
developing female reproductive tract. Thus,
dysregulation of the expression of genes
involved in signaling and pattern formation
during development may underlie the terato-
genic effects of DES on the developing
reproductive tract. Other compounds with
estrogenic activity for which developmental
toxicity has been reported include other
analogs of estradiol, pesticides, industrial
chemicals such as methoxychlor, kepone,
dioxins, bisphenolA, and phytoestrogens such
as genistein and coumestrol [reviewed by
Barlowet al. (80)]. In rats, cryptorchidismwas
induced with a suspected estrogenic contami-
nant, mono-n-butyl phthalate (87).
Androgen-receptor-mediated events are
inhibited by pesticides such as vinclozolin,
procymidone, or p,p'-DDE. These com-
pounds block androgen-induced gene
expression, delay puberty, reduce sex acces-
sory gland size, and alter sexual differentia-
tion in the male rat (88-90). Exposure of
male rats (GD 12-21) to phthalates (which
are estrogenic in vitro but not in vivo) causes
malformations that appear to result from
antagonism ofandrogens in utero (91). These
malformations include hypospadias; cryp-
torchidism; agenesis of the prostate, epi-
didymis, and vas deferens; degeneration of
the seminiferous epithelium; and interstitial
cell hyperplasia of the testis. Flutamide, an
androgen receptor antagonist, produced the
same malformations in addition to inducing
retained thoracic nipples, decreased anogeni-
tal distance, and a high incidence ofinguinal
testes. Treatment of pregnant sows with
flutamide induced cryptorchidism (92).
Inhibitors of 5a-reductase, such as finas-
teride, also affect the masculinization ofthe
urogenital sinus and external genitalia, events
that are dependent on DHT (93). Prenatal
administration ofan aryl hydrocarbon recep-
tor agonist [tetrachlorodibenzo-p-dioxin
(TCDD)] produces a different spectrum of
effects, including reduced ejaculated sperm
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numbers in male rats (94). TCDD may also
have direct effects on steroidogenesis.
Humans. Prenatal exposure to androgens,
estrogens, and agents that mimic steroidal
hormones can affect development of the
reproductive system in both males and
females. The classic example is the set of
development effects due to exposure to DES
in utero. Transplacental effects ofDES were
demonstrated initially in reports associating
clear-cell adenocarcinoma of the vagina in
adolescent women with prior exposure to
DES in utero (95). Male offspring ofmothers
exposed to DES also have abnormalities of
their reproductive tracts. This was demon-
strated in a prospective double-blind study to
evaluate the efficacy ofDES for the protection
ofpregnancy; 840 pregnant women received
DES and 806 pregnant women received
placebo. Of the male progeny, 41 of 159
(25%) ofthose exposed to DES in utero, as
compared to 11 of 161 (7%) ofthose exposed
to placebo in utero, had epididymal cysts,
hypotrophic testes, and induration ofthe cap-
sule ofthe testis (96). Oligospermia (sperm
concentration < 20 million sperm/mL) was
found in 9 of31 (29%) ofmen exposed to
DES compared to 0 of 20 men exposed to
placebo. To date there is no evidence for
development ofmalignant lesions in male off-
spring exposed prenatally to DES. Although
DES is no longer given to pregnant women,
environmental toxicants that mimic gonadal
steroids remain aconcern today.
There is some debatable evidence that
sperm counts have declined over a 50-year
period between 1938 and 1991 (97); there
may be a concomitant increase in the preva-
lence of cryptorchidism and hypospadias
(97,98). Although the cause(s) behind failure
of the testis to descend remain unknown,
there is evidence from both epidemiological
studies and animal experiments which sug-
gests that man-made chemicals induce
maldescent of the testis and may be incul-
pated as potential etiologic factors (99-102).
An increase in the incidence of cryp-
torchidism has been reported for boys with
higher levels ofpesticide exposure as deter-
mined by place of residence (102). Lower
circulating levels of testosterone have been
demonstrated during gestation weeks 6-14
in boys with cryptorchidism (103).
Postnatal Exposures
Animals. There is a consistent decline in
oocyte numbers from just before birth until
the completion of the reproductive lifespan
ofthe female. Postnatal exposures may affect
this decline or may affect the development
ofsecondary sex characteristics and the trig-
gering of the ovulation process. Effects of
toxicants on the imprinting ofsexual behav-
ior in the brain are probably mediated by
steroid receptors in specific nudei ofthe brain.
In addition, manychemicals that affect the tis-
sues ofthe reproductive system are likely to do
so by targeting the hypothalamic-pituitary
complex. Decreased or altered function of
these tissues results in reduced gonadotropin
output and function ofgonadal and repro-
ductive tract tissues. An example ofan agent
that has multiple actions on male reproduc-
tion is estradiol. Although estradiol effec-
tively reduces testicular weight, sperm
counts, and the weights of the epididymis,
prostate, and seminal vesicles, most ofthese
effects are due to a decrease in serum LH
and testosterone caused by the inhibitory
action of estrogens at the hypothalamic-
pituitary level in the male (104). However,
estradiol receptors are also found in the
testis, efferent ducts, epididymis, and
prostate; mice bearing a null mutation in the
estrogen a-receptor are infertile due, at least
in part, to the inability of the efferent ducts
to resorb fluid (105). Because steroid hor-
mones and their receptors regulate the func-
tions of many tissues and processes, it is
clear that the consequences of exposure to
endocrine disruptors are varied. One ofthe
important targets for toxicant action in the
reproductive system may be the timing of
pubertal development. Extensive reviews are
currently available in the literature on the
effects ofprepubertal exposure to endocrine-
disrupting chemicals on sexual maturation
in the rat (89,90).
In addition to targeting germ cells, toxi-
cants can also target either Sertoli or Leydig
cells. In young male rats, exposure to mono-
(2-ethylhexyl)phthalate or 2,5-hexanedione
causes the collapse ofSertoli cell cytoskeletal
elements and a concurrent increase in germ
cell apoptosis (106,107). Because Sertoli cells
do not proliferate beyond postnatal day 16,
the death ofSertoli cells has long-term conse-
quences for spermatogenesis. Interestingly,
Sertoli cell expression ofFas ligand, a key reg-
ulator ofapoptosis, may be up-regulated by
toxicants. Fas ligand in turn may induce the
apoptosis ofgerm cells by interacting with its
receptor, Fas. Fas gene expression is up-regu-
lated by agents that cause germ cell injury,
leading to the elimination of Fas-positive
germ cells that can no longer be supported
(106). Prolongation ofthe period in which
Sertoli cells proliferate is also possible; neo-
natal treatment of rats with Aroclor 1254
(inducing hypothyroidism) increases testis
weight and sperm production, presumably by
increasing Sertoli cell numbers (108).
Leydig cells normally do not proliferate in
the adult. However, unlike Sertoli cells,
Leydig cells proliferate to reestablish their cell
numbers ifthey are destroyed with ethane
dimethane sulfonate, a chemical that selec-
tively and effectively targets Leydig cells
(109,110). Chemicals such as reserpine or
finasteride can induce Leydig cell hyperplasia
after protracted exposures, especially in
rodents [reviewed byThomas (111)].
Epididymis-specific toxicants may affect
spermatozoal maturation and storage.
Exposure to one such chemical, chloroethyl-
methanesulfonate, results in a decrease in
both testosterone levels and spermatozoal epi-
didymal transit time (112). Another example
ofa drug acting on the epididymis is methyl
chloride. The administration ofmethyl chlo-
ride can cause an increase in dominant lethal
mutations (mutations in sperm that result in
embryolethality in the progeny) as a conse-
quence ofa selective inflammatory action of
this agent on the epididymis (113).
In the first few days after birth, testicular
androgen production is responsible for
imprinting male sexual behavior and growth
hormone secretion pattern. Subsequently,
there is a rapid proliferation ofLeydig cells
between days 14 and 28 in the rat, followed
by one more cell division between days 28
and 56. Androgen production increases
slowly until day 28, and then rapidly, to
plateau by day 56 (114). The presence ofspe-
cific accessorysex organs is species dependent;
however, they all depend on the presence of
androgen. In response to the rapid increase in
androgen production between days 28 and
56, there is rapid proliferation and differenti-
ation ofthe various lobes ofthe prostate as
well as the seminal vesicles. The differentia-
tion of the epididymal epithelial cell types
occurs between days 14 and 56 in response to
androgens and to the arrival, from the rete
testis, ofgerm cells and the contents of the
fluid bathing them.
In female animals, experiments have
revealed the effects ofman-made chemicals on
ovarian follicle countswithout necessarily pro-
viding any evidence ofan effect on circulating
hormone levels, fecundity, or fertility. The
effects ofexogenous agents on ovarian follide
recruitment, growth, differentiation, and atre-
sia are important to study.
Literally hundreds ofscientific publica-
tions demonstrate that prenatal and neonatal
exposures to several classes ofexogenous estro-
gens or androgens affect sexually dimorphic
CNS development in experimental animals
(115,116). The estrogenic effects ofsynthetic
compounds, in particular DDT and its
analogs, have been extensively reported and
persuasively shown to induce adverse effects if
the exposures occur during a developmentally
sensitive interval. Whereas part ofthe repro-
ductive failure ofsheep grazed on pastures
exposed to estrogenic substances is due to
alterations in genital tract development ofthe
female offspring, alterations have also been
reported in behavior and neuroendocrine end
points [reviewed by Kaldas and Hughes
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(117)]. Exposure ofrats during development
to common dietary phytoestrogens genistein
and coumestrol at concentrations representa-
tive (scaled to body mass or caloric intake) of
the levels consumed by women eating a tradi-
tional Asian diet, alters normal sexually
dimorphic end points of hypothalamic
anatomy and neuroendocrine functions; these
effects are similar to those ofDES or estradiol,
albeit at amuch lowerpotency.
Interference with normal brain-pituitary-
gonadal function during the perinatal period
(e.g., with a GnRH analog in monkeys)
impacts adversely on subsequent reproduc-
tive, immunological, and behavioral func-
tions. Studies in male monkeys suggest that
the perinatal reproductive hormonal environ-
ment plays an important role in shaping later
measures ofperipubertal and adult reproduc-
tive status (118-125). Continuous GnRH
agonist or GnRH antagonist treatment of
neonatal male rhesus monkeys suppresses the
pituitary-testicular axis and affects later
peripubertal testicular function. Monkeys
treated neonatally with a GnRH agonist
exhibited subnormal sensitivityofthe CNS to
the excitatory amino acids aspartate and glu-
tamate, suggesting that abolishing neonatal
activation ofthe pituitary-testicular axis with
a GnRH agonist permanently alters differen-
tiation ofcentral nervous system centers that
are either involved in GnRH secretion or
govern this process. Endocrine function and
sexual behavior of the treated males were
examined, with ovariectomized female mon-
keys receiving periodic estradiol treatment
during the breeding and nonbreeding
seasons. During the breeding season, there
were no differences between treated and con-
trol males in the levels of LH and testos-
terone or in frequency of copulatory
behavior. However, treated males mastur-
bated less frequently than controls when the
females were not given estradiol. During the
nonbreeding season, treated males had lower
testosterone levels than controls when the
females were not receiving estradiol and cop-
ulated less when the females received estra-
diol, even though testosterone levels were
comparable. These results suggest that the
induction of reversible hypogonadotropic
hypogonadism in neonatal male monkeys
alters subsequent testicular development,
peripubertal endocrine physiology, and sex-
related behavior. Thus, perinatal activity of
the pituitary-testicular axis appears to define
a critical window ofdevelopment for repro-
duction in male primates.
Synaptic reorganization of the brain
continues throughout life and is sensitive to
gonadal steroids. Treatment of sexually
immature female rats with exogenous 17a-
estradiol or pregnant mare serum gonado-
tropin (PMSG) results in precocious puberty
and increased synaptic contacts per unit area
in the arcuate nucleus (ARCN) ofthe brain
(126-129). PMSG presumably acts through
the ovary to induce estrogen synthesis, which
acts on the brain to increase the number of
synapses per unit area of the ARCN.
Therefore, chemical mixtures that possess
hormone-mimicking activity have the poten-
tial to alter the ontogeny ofsynapse forma-
tion in the ARCN and affect the age ofonset
ofpuberty.
Humans. The testis is subject to damage
from chemotherapeutic agents given during
childhood. In fact, because adolescence
marks an exponential increase in germ cell
production and testicular size, this is likely to
be a particular period ofvulnerability to toxi-
cants. Germ cells in the prepubertal testis are
at least as sensitive to cytotoxic agents as in
the adult (66). In one study of long-term
survivors of childhood cancer, 6 of 13
patients treated prepubertally had a normal
or near-normal reproductive state compared
to 7 of 14 treated postpubertally (129).
Interestingly, tests to detect abnormal testic-
ular function, such as basal levels ofgonado-
tropins andgonadotropin response to GnRH,
are unlikely to detect testicular damage in
prepubertal boys (130). This is illustrated by
the case of a 6-year-old boy who received
chemotherapy and had normal FSH levels
prepubertally but then had abnormally high
levels ofFSH in early puberty (130). Leydig
cell function is generally not affected by
chemotherapy in the prepubertal male, as
assessed by mean baseline and GnRH-stimu-
lated LH levels and onsetofpuberty (131). In
the same study, pubertal boys had an elevated
LH response to GnRH stimulation that may
have reflected a mild Leydig cell dysfunction
in this older group. Direct irradiation to the
prepubertal testis is more likely to cause
Leydig cell damage than radiation treatment
to the postpubertal testis (132).
A brief report of four pubertal patients
(ranging from 10 to 18 years old) who
received cyclophosphamide for treatment of
nephritis suggests that this may be a window
or sensitive period during which the testis is
more susceptible to damage (133). Testicular
biopsies from two ofthe patients showed sig-
nificant effects on the seminiferous tubules,
whereas biopsies from the other two patients
were unremarkable. The two affected patients
received more cyclophosphamide per body
weight andwere treated earlier in puberty than
the two unaffectedpatients.
In contrast to the male, the number of
germ cells in the female only decreases after
birth. The decrease in the actual number of
oocytes is very rapid during the period from
birth to puberty. Postnatal exposures may
affect this decline, potentially inducing prema-
ture reproductive senescence, ormayaffect the
development ofsecondary sex characteristics
and the triggering ofthe ovulation process.
Numerous animal experiments have demon-
strated that the follicular reserve is affected by
cigarette smoke and various industrial chemi-
cals such as polycyclic aromatic hydrocarbons
(134-136). However, few clinical studies have
been done in human populations and these
have tended to focus on populations with
unique exposures. Only cigarette smoke has
been clearly associated with an earlier onset of
menopause. The effects ofcigarette smoking
also appear to be transgenerational.
Mammary tissue can respond to endo-
genous sex steroids produced by the neonatal
gonad, but the importance ofthis target tissue
in terms ofconsequences on later function or
disease riskis unknown.
The susceptibility ofelderly males and
females to chemical insult deserves more
attention but is not the focus ofthis paper.
Similarities and Differences
between Humans and
LaboratoryAnimals
As expected, there are many similarities
regarding the major hallmarks ofreproduc-
tion among most mammals examined.
These include similarities in tissue architec-
ture, both during development and in the
adult, in homeostatic mechanisms, and in
specific gene expression in various tissues of
the reproductive system. In both humans
and the animal models usually studied,
gametes are produced in far greater excess
than would seem to be necessary for the sur-
vival ofspecies. Ten to hundreds ofmillions
ofspermatozoa are generated daily by most
adult male mammals, yet very few of these
germ cells succeed in transmitting their
genetic material to the next generation.
Although the number of oocytes produced
in mammalian females is more limited, and
this production occurs only during fetal life,
most ovaries contain several orders ofmag-
nitude more oocytes than ever will be fertil-
ized. Two of the most striking differences
between laboratory animals and humans are
the relatively poor quality ofhuman sperma-
tozoa and the high level offetal loss exhib-
ited by humans. Embryolethality occurs at a
very low incidence in outbred strains ofrats
and mice, yet fetal wastage has been esti-
mated to vary from 43 to 78% offertilized
human ova; it is thought that approximately
20-30% ofimplanted fertilized eggs will be
lost, whereas clinically recognized pregnancy
loss is about 10-12%. Malformations are
also relatively rare in the animal models
studied most often (e.g., Sprague-Dawley
rats), but the rate for major malformations
in humans is typically 3-4%, and may be up
to 8-12% when major and minor malfor-
mations are combined.
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Another difference between humans and
animals is the relative time allocation for the
various phases of differentiation during
embryonic and fetal life (Figures 1 and 2).
The animal species frequently chosen as mod-
els have a short period to sexual maturity, a
short gestational period, and large litter size.
For example, organogenesis in mice and rats
occurs within a week (approximately GD
8-15) compared to embryonic weeks 4-8 in
humans. Gamete migration in mice and rats
takes only a day or two, as opposed to weeks
in humans. The spermatogenic cycles in
experimental animals differ from humans in
length but are nevertheless very similar physi-
ologically. Similarly, differentiation of the
gonads in rodents appears from GD 12 to 15,
in contrast to weeks 8-12 in humans. Our
current knowledge and understanding of
comparative embryology and physiology
enables us to use animal models to compare
comparables. That is, we can study the effects
of a toxicant or exposure on specific events
within the critical window of develop-
ment/exposure for that event in various
model species.
That the timeline is condensed in many
of our experimental animal models is a
tremendous advantage; studies can take place
over a much shorter time frame, reducing the
time and investment required to find an
answer. Experimental animals may be more
sensitive to the developmental effects of
exogenous substances because of the rapid
rate at which cell proliferation, migration,
and differentiation occur. In fact, there are
few specific examples of toxicants to which
experimental animals are relatively insensitive
compared to humans; often the basis for this
relative insensitivity is that there are differ-
ences in toxicokinetics or metabolism
between the species.
The rat is the most commonly used
animal model for basic and applied research
in reproductive and developmental toxicol-
ogy. One of the reasons is that there is a
tremendous database in industry, regulatory
agencies, and academia on the effects oftoxi-
cants in this species and on the normal vari-
ants in development. Yet many of the
breakthroughs in terms of the molecules
involved in regulating embryonic pattern for-
mation and gene function are made today
using transgenic null mutation mice. The
development ofan equivalent for rat to the
embryonic stem cell/homologous recombina-
tion technology we now use in mice would be
a boon to all toxicologists. It is likely that the
rat genome will be sequenced within a few
years ofthat for the mouse and human. The
advances under way in genomics and pro-
teomics will impact in the very near future on
the realm ofwhat is possible in reproductive
toxicology. Using these approaches we should
soon have the ability to define the molecule
or pathway targeted by a toxicant and to use
this information to cross species barriers.
Objectives to Fill Gaps in the
Knowledge Base
* Link and improve human exposure and
outcome data
* Improve understanding ofthe basic mech-
anisms and the molecules regulating cellu-
larevents in the reproductive system
* Elucidate the specific cellular and molecu-
lar targetsofknown toxicants
* Develop surrogate markers ofexposure,
effect, and susceptibility that are minimally
invasive
* Design in vitro tests to assess reproductive
system function during embryonic, post-
natal, andadult life
* Design a systematic approach to the identi-
fication ofreproductive toxicants
* Develop sensitive, specific, and predictive
animal models forkey human reproductive
anddevelopmental processes ofconcern
* Validate existing test methods used in
reproductive biology studies for potential
application in regulatory reproductive toxi-
citytesting.
Summary and Conclusions
There is clear evidence that there are precon-
ceptional, prenatal, and postnatal exposures
to environmental and therapeutic chemicals
that can affect specific components of the
male and female reproductive systems. The
range ofthese effects encompasses infertility,
which can result from arrested gametogenesis,
to early embryo loss or malformations ofthe
gonads and specific tissues ofthe reproductive
system. Precise information is lacking regard-
ing the risks to humans oflow-level exposures
to many environmental contaminants.
Animal models are useful for hazard identifi-
cation ofknown high dosages ofchemicals,
but the apical outcomes measured (genital
tract development, fertility, and birth defects)
are not designed to detect subtle changes in
gene or cellular function that could lead to
adverse health effects in humans after long-
term or low-dose exposures. Even for those
chemicals that have been identified as repro-
ductive system toxicants, we frequently do
not know the cellular or molecular mecha-
nisms of action. Elucidation of the target
molecules for reproductive system toxicants
will permit the establishment ofthe biomark-
ers ofeffect that are needed forhazard charac-
terization and risk assessment. Elucidation of
thewindows in time when components ofthe
reproductive system are most susceptible to
insult will be valuable in understanding the
underlying pathology and in developing
strategies to prevent exposures leading to
adverse effects on reproduction.
Although it is the dose that makes the
poison, there is no doubt that timing ofthe
exposure may be as important as dose in
determining the potential toxicity ofa com-
pound to the reproductive system. Further-
more, although early embryogenesis is clearly
a critical window during which exposure to
exogenous chemicals, both naturally occurring
and man-made, mayhave profound and long-
lasting adverse effects on reproductive struc-
ture and function, preconceptional and
postnatal exposures may also adversely affect
the reproductive system and progenyoutcome.
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